In July 2023, the first-ever over-the-counter (OTC) daily birth control pill, Opill, a progestin-only pill, was approved by the US Food and Drug Administration (FDA). Three years later, generic versio...

Want to help us spread the word? We've created a series of zines--short DIY publications--to raise awareness and amplify evidence-based information about birth control pills and over-the-counter access! Check out this video from Advocates for Youth, ...

This blog was coauthored by Kelly Blanchard, Free the Pill Steering Committee member and President of Ibis Reproductive Health, and Dr…

Want to help us spread the word? We’ve created a series of zines—short DIY publications—to raise awareness and amplify evidence-based information about birth control pills and over-the-counter access!...

If you’re interested in receiving free birth control products to distribute in your community, this training is for you! Learn more about Opill—the first-ever, over-the-counter (OTC) daily birth control pill available in the United States—and how you can distribute it for free in y

This blog was authored by Victoria Nichols, Free the Pill Senior Project Director at Ibis Reproductive Health

This blog was authored by Victoria Nichols, Free the Pill Senior Project Director at Ibis Reproductive Health

In July 2023, the first-ever over-the-counter (OTC) daily birth control pill, Opill, a progestin-only pill, was approved by the US Food and Drug Administration (FDA). Three years later, generic versio...

This cross-sectional study evaluates whether the newly available over-the-counter progestin-only oral contraceptive pill in the US is associated with increased contraceptive use among individuals with...

The ruling in West Virginia v. B.P.J. leaves open the door to inclusive policies, writes attorney Shannon Minter.